Sarda Proteins Ltd
₹ 137
4.99%
18 Sep
10:24 a.m.
- Market Cap ₹ 123 Cr.
- Current Price ₹ 137
- High / Low ₹ 137 / 60.0
- Stock P/E 44.2
- Book Value ₹ 96.0
- Dividend Yield 0.00 %
- ROCE 1.45 %
- ROE 1.02 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 80.7% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.98% over last 3 years.
- Earnings include an other income of Rs.5.83 Cr.
- Working capital days have increased from 780 days to 1,729 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.02 | 2.06 | 6.18 | 5.65 | 7.22 | 5.40 | 11.36 | 10.76 | 5.80 | 1.30 | 24.18 | 16.16 | 18.19 | |
| 5.14 | 2.18 | 6.35 | 6.00 | 7.33 | 5.31 | 11.38 | 10.50 | 5.95 | 1.45 | 24.16 | 15.87 | 20.69 | |
| Operating Profit | -0.12 | -0.12 | -0.17 | -0.35 | -0.11 | 0.09 | -0.02 | 0.26 | -0.15 | -0.15 | 0.02 | 0.29 | -2.50 |
| OPM % | -2.39% | -5.83% | -2.75% | -6.19% | -1.52% | 1.67% | -0.18% | 2.42% | -2.59% | -11.54% | 0.08% | 1.79% | -13.74% |
| 0.80 | 0.00 | 0.00 | -0.01 | 0.03 | 0.08 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.35 | 5.83 | |
| Interest | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.62 | -0.17 | -0.19 | -0.37 | -0.09 | 0.17 | 0.06 | 0.35 | 0.01 | 0.02 | 0.02 | 0.64 | 3.33 |
| Tax % | 4.84% | -5.88% | -31.58% | -10.81% | 44.44% | 82.35% | 133.33% | 14.29% | 500.00% | 0.00% | 100.00% | 28.12% | |
| 0.59 | -0.15 | -0.13 | -0.33 | -0.12 | 0.03 | -0.02 | 0.31 | -0.03 | 0.02 | 0.01 | 0.45 | 2.78 | |
| EPS in Rs | 1.80 | -0.87 | -0.75 | -1.91 | -0.70 | 0.17 | -0.12 | 1.80 | -0.17 | 0.12 | 0.06 | 0.50 | 4.41 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 7% |
| 3 Years: | 41% |
| TTM: | -48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 90% |
| 3 Years: | 157% |
| TTM: | 813% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 43% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.43 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 9.75 |
| Reserves | 0.30 | 0.15 | 0.02 | -0.31 | -0.44 | -0.41 | -0.43 | -0.12 | -0.15 | -0.13 | -0.13 | 76.45 |
| 0.21 | 0.61 | 0.20 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.20 | 0.21 | 0.20 | 0.13 | 0.12 | 0.06 | 0.07 | 0.07 | 0.05 | 0.07 | 0.27 | 0.45 | |
| Total Liabilities | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.64 | 86.65 |
| 0.10 | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.03 | 3.40 | 2.86 | 2.28 | 2.17 | 2.14 | 2.13 | 2.45 | 2.40 | 2.44 | 2.64 | 86.64 | |
| Total Assets | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.64 | 86.65 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.72 | -1.20 | -0.09 | 0.48 | -0.59 | -0.05 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.36 | |
| 1.90 | 0.20 | 0.00 | 0.02 | 0.11 | 0.09 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.36 | |
| -0.13 | 0.37 | -0.42 | -0.20 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 83.49 | |
| Net Cash Flow | 1.05 | -0.63 | -0.51 | 0.30 | -0.47 | 0.03 | 0.03 | 0.19 | -0.14 | -0.07 | -0.08 | 7.49 |
| Free Cash Flow | 0.73 | -1.18 | -0.09 | 0.48 | -0.59 | -0.04 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.35 |
| CFO/OP | 525% | 1,000% | 53% | -134% | 536% | -22% | 200% | 38% | 200% | 153% | -550% | -26,331% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.81 | 0.00 | 38.98 | 44.58 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | 93.51 |
| Inventory Days | 32.70 | 324.22 | 64.41 | 28.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 0.76 | 0.00 | 0.61 | 0.00 | ||||||||
| Cash Conversion Cycle | 45.75 | 324.22 | 102.78 | 73.22 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | 93.51 |
| Working Capital Days | 65.44 | 251.60 | 108.08 | 76.23 | 83.92 | 114.91 | 55.91 | 64.45 | 130.27 | 603.65 | 5.89 | 1,729.23 |
| ROCE % | -5.93% | -4.52% | -6.02% | -14.66% | -5.63% | 8.17% | 2.88% | 15.73% | 0.42% | 0.85% | 0.84% | 1.45% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mustard Oil share of revenue % |
|
|||||||||
| Number of employees count |
||||||||||
| Number of products actively traded (with positive revenue) count |
||||||||||
| Solar Cell share of revenue % |
||||||||||
| Top product share of revenue % |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Clarificaion Of Price Movement
- Company denies any undisclosed material event behind recent share price movement.
-
CLARIFICATION FOR PRICE MOVEMENT
- Sarda Proteins replies to BSE price movement query, citing market forces and no undisclosed events.
-
Announcement under Regulation 30 (LODR)-Change of Company Name
- Company renamed to FRESITA PROTEINS LIMITED; new scrip ID FRESITA effective September 21, 2026.
-
Clarification sought from Sarda Proteins Ltd
- Exchange has sought clarification from Sarda Proteins Ltd on September 16, 2026 with reference to significant movement in price, in order to ensure that investors …
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2][3]
a) SPL used to deal in the protein products
and various other food products.
b) However, on 4th Sept 2024, the company resolved to switch its business to Power Industry for solar cell manufacturing and to deal
into dealing with all the machinery, instruments, and equipment for solar cell manufacturing
and solar power generation.
c) Hence, the company changed and
added a business objective to deal with
the renewable energy sector and solar
cell products.
d) Currently, it has core expertise in solar plant services, carbon-credit markets, intelligent asset management, and advanced automation technologies.